Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s):  MEDXF

Healthcare Biotechnology
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:MDP)

Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada

Newsfile April 17, 2025

Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection

Newsfile April 7, 2025

Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.

Newsfile March 14, 2025

Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection

Newsfile February 24, 2025

Canadian Investment Regulatory Organization Trade Resumption - MDP

Canada NewsWire February 6, 2025

Canadian Investment Regulatory Organization Trading Halt - MDP

Canada NewsWire February 6, 2025

Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States

Newsfile February 5, 2025

Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada

Newsfile February 4, 2025

Medexus Schedules Third Fiscal Quarter 2025 Conference Call

Newsfile January 31, 2025
View More News ››

Opinion & Analysis (TSX:MDP)

VIDEO: Focused on Children's Medicine in an Underserved Market

BTV-Business Television June 8, 2016

Pediapharm (V.PDP) is a very attractive takeover candidate, Stockhouse poster says

Stockhouse Editorial April 20, 2015
View More Opinion ››

Bullboard Posts (TSX:MDP)

smallcapdiscoveries.com interview

https://www.youtube.com/watch?v=oTkppTgGhd4
Possibleidiot01 - March 19, 2025

RE:Assessment

I screened these guys the other day. Look attractively valued for what's ahead this year. Started a position.
MintyZyn - March 10, 2025

Assessment

20% below the financing level + this = just opened a small position. GLTA Would welcome your analysis on this small cap. It has recently...
retiredcf - February 10, 2025

$4 financing

Houston, we have a problem?
thedave2006 - February 6, 2025

FDA Approval of GRAFAPEX, 100m rev projected~5yr

https://ca.finance.yahoo.com/news/medexus-announces-fda-approval-grafapex-155900222.html
SushiGobbler - January 23, 2025

$100M shelf prospectus filed

On sedar.
lscfa - November 8, 2024
View more Bullboard ››

Eastern Platinum Ltd.

Eastern Platinum Ltd.

Eastern Platinum Limited owns directly and indirectly a number of platinum group metals (PGM) and chrome assets in the ...
View More »